Heldman, Madeleine RKates, Olivia SSafa, KassemKotton, Camille NMultani, AshritGeorgia, Sarah JSteinbrink, Julie MAlexander, Barbara DBlumberg, Emily AHaydel, BrandyHemmige, VagishHemmersbach-Miller, MarionLa Hoz, Ricardo MMoni, LissetCondor, YesabeliFlores, SandraMunoz, Carlos GGuitierrez, JuanDiaz, Esther IDiaz, DanielaVianna, RodrigoGuerra, GiselleLoebe, MatthiasYabu, Julie MKramer, Kailey HughesTanna, Sajal DIson, Michael GRakita, Robert MMalinis, MaricarAzar, Marwan MMcCort, Margaret ESingh, Pooja PVelioglu, ArzuMehta, Sapna Avan Duin, DavidGoldman, Jason DLease, Erika DWald, AnnaLimaye, Ajit PFisher, Cynthia EUW Covid-19 SOT Study Team2022-10-032022-10-032022-021058-48381537-6591https://hdl.handle.net/10161/26024<h4>Introduction</h4>Most studies of solid organ transplant (SOT) recipients with COVID-19 focus on outcomes within one month of illness onset. Delayed mortality in SOT recipients hospitalized for COVID-19 has not been fully examined.<h4>Methods</h4>We used data from a multicenter registry to calculate mortality by 90 days following initial SARS-CoV-2 detection in SOT recipients hospitalized for COVID-19 and developed multivariable Cox proportional-hazards models to compare risk factors for death by days 28 and 90.<h4>Results</h4>Vital status at day 90 was available for 936 of 1117 (84%) SOT recipients hospitalized for COVID-19: 190 of 936 (20%) died by 28 days and an additional 56 of 246 deaths (23%) occurred between days 29 and 90. Factors associated with mortality by day 90 included: age > 65 years [aHR 1.8 (1.3-2.4), p =<0.001], lung transplant (vs. non-lung transplant) [aHR 1.5 (1.0-2.3), p=0.05], heart failure [aHR 1.9 (1.2-2.9), p=0.006], chronic lung disease [aHR 2.3 (1.5-3.6), p<0.001] and body mass index ≥ 30 kg/m 2 [aHR 1.5 (1.1-2.0), p=0.02]. These associations were similar for mortality by day 28. Compared to diagnosis during early 2020 (March 1-June 19, 2020), diagnosis during late 2020 (June 20-December 31, 2020) was associated with lower mortality by day 28 [aHR 0.7 (0.5-1.0, p=0.04] but not by day 90 [aHR 0.9 (0.7-1.3), p=0.61].<h4>Conclusions</h4>In SOT recipients hospitalized for COVID-19, >20% of deaths occurred between 28 and 90 days following SARS-CoV-2 diagnosis. Future investigations should consider extending follow-up duration to 90 days for more complete mortality assessment.UW Covid-19 SOT Study TeamDelayed mortality among solid organ transplant recipients hospitalized for COVID-19.Journal article2022-10-03